Understanding Global Regulatory Requirements for Nasal Drug Products
This presentation examines global regulatory requirements along with regulatory approaches for bioequivalence and an overview of FDA drug specific guidance.
Brazilian National Sanitary Surveillance Agency (ANVISA) Certifies Next Breath as a Center for In Vitro Pharmaceutical Equivalence
Baltimore, USA – March 28th, 2014 - Next Breath is pleased to announce that the Brazilian National Sanitary Surveillance Agency [...]